跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Febsan 80 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Febsan 80
Approved
STANDARD
Febsan 80
ACME Formulations Pvt.Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
478448f332b340dc
Company
ACME Formulations Pvt.Ltd
Type
Standard
Approval Details
Approval Id
478448f332b340dc
Drug Approval Philippines Name
Febsan 80
Product Name
Febsan 80
Registration Number
DRP-13227
Brand Name
Febsan 80
Generic Name
Febuxostat
Dosage Form
Film Coated Tablet
Dosage Strength
80 mg
Manufacturer
ACME Formulations Pvt.Ltd
Importer
SRS Life Sciences Inc.
Distributor
IMV Gemini Pharma Inc.
Issuance Date
28 August 2024
Expiry Date
29 October 2029
Pharmacologic Category
Antihyperuricemia
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
478448f332b340dc
Type
Standard
Back to Philippines FDA Approvals